RNLX

Renalytix AI PLC

Price

return (12m)

p/e

-0.40

p/bv

-1.72

DIVIDEND YIELD

0.00%

RNLX price

Renalytix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment RNLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RNLX

Valuation

P/E

-0.40

Sector 0.84

Industry -1.42

P/BV

-1.72

Sector 1.82

Industry 1.25

P/Revenue (PSR)

5.89

Sector 1.48

Industry 2.13

EV/EBITDA

-2.41

Sector -43.66

Industry -35.45

EV/EBIT

-2.38

Sector -47.57

Industry -38.86

P/EBITDA

-0.72

Sector -31.25

Industry -21.12

P/EBIT

-0.67

Sector -42.58

Industry -25.59

P/Total Assets

1.70

Sector 0.82

Industry 0.70

P/Net Current Assets

-1.39

Sector -23.77

Industry -59.56

P/Working Capital

-2.52

Sector -3.73

Industry -1.93

EPS

-0.48

Sector -0.70

Industry -1.22

BVPS

-0.11

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

6.79%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-927.12%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.07

Sector 0.13

Industry 0.06

Profitability

ROE

426.10%

Sector -24.30%

Industry -38.97%

ROA

-419.69%

Sector -24.50%

Industry -49.14%

ROIC

-191.92%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.53

Sector 1.92

Industry 2.55

Net Debt / EBITDA

0.06

Sector -23.10

Industry -8.80

Net Debt / EBIT

0.06

Sector -17.84

Industry -36.75

Net Debt / Equity

0.04

Sector -0.68

Industry -1.16

Gross Debt / Equity

-0.55

Sector -0.72

Industry -0.54

Equity/Assets

-0.98

Sector 0.46

Industry 0.52

Liabilities/Assets

-0.98

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

-1.01%

Sector -

Industry -

5Y Earnings CAGR

-4.26%

Sector -

Industry -

Fundamentals RNLX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RNLX Renalytix AI PLC	$0.00	-	0.00%	-0.40	-1.72	426.10%	-100.00%
WST West Pharmaceutical Services Inc	$384.38	42.49%	0.24%	45.53	8.60	18.89%	16.98%
OPRX OptimizeRx Corporation	$8.56	-56.21%	0.00%	35.89	1.26	3.51%	4.66%
RVTY Revvity Inc.	$152.89	64.19%	0.18%	71.73	2.37	3.31%	8.22%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RNLX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Renalytix

Renalytix AI PLC

Average Investor10 user rating

4.0 (0 people)

United States

8 years

Founded: 2018

2020

Time since IPO - 6 years

9

Employees

Renalytix AI PLC (United States) is listed on the Nasdaq and has a market capitalization of $13.52 million, with shareholders equity totaling $-7.85 million.

The company employs approximately 9 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, Renalytix AI PLC reported $2.30 million in revenue, generating net income of $-33.45 million.

Key financial metrics include a P/E ratio of -0.40, a price-to-book (P/B) ratio of -1.72, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RNLX.

Market cap

$13.52 million

Net worth

$-7.85 million

$-7,850,000.00

Assets

$7.97 million

$7,970,000.00

Total Shares Outstanding

69.00 million

69,000,000

Average Daily Trading Volume

$189.45 Thousand

$189,446.48

Sector

Health

Industry

Health Technology

RNLX

RNLX revenue and profits

Financial Results RNLX

DRAG THE FRAME TO SEE MORE DATA

RNLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76